Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Fibrous Dysplasia, Polyostotic

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Fibrous Dysplasia, Polyostotic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Casselman, JW; D'Hont, G; De Clercq, C; De Jonge, I; Neyt, L1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Fibrous Dysplasia, Polyostotic

ArticleYear
MRI in craniofacial fibrous dysplasia.
    Neuroradiology, 1993, Volume: 35, Issue:3

    Topics: Adolescent; Adult; Contrast Media; Facial Bones; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Monostotic; Fibrous Dysplasia, Polyostotic; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Jaw Diseases; Magnetic Resonance Imaging; Middle Aged; Orbital Diseases; Organometallic Compounds; Skull; Sphenoid Bone; Temporal Bone

1993